Research Paper Volume 9, Issue 8 pp 1926—1940

Chronic exercise reduces hypothalamic transforming growth factor-β1 in middle-aged obese mice

Vagner R. R. Silva1,2, , Carlos K. Katashima2, , Luciene Lenhare1,2, , Carla G. B. Silva2, , Joseane Morari4, , Rafael L. Camargo2, , Licio A. Velloso4, , Mario A. Saad2, , Adelino S. R. da Silva5, , Jose Rodrigo Pauli1,3, , Eduardo Rochete Ropelle1,2,3, ,

  • 1 School of Applied Sciences, University of Campinas, Limeira, SP, Brazil
  • 2 Department of Internal Medicine, University of Campinas, Campinas, SP, Brazil
  • 3 CEPECE - Research Center of Sport Sciences, School of Applied Sciences, University of Campinas, Limeira, SP, Brazil
  • 4 Laboratory of Cell Signaling, Obesity and Comorbidities Research Center, University of Campinas, Campinas, 1308-970, Brazil
  • 5 Postgraduate Program in Rehabilitation and Functional Performance, Ribeirão Preto Medical School, USP, School of Physical Education and Sport of Ribeirão Preto, University of São Paulo, Ribeirão Preto, SP, Brazil

Received: July 9, 2017       Accepted: August 25, 2017       Published: August 28, 2017      

https://doi.org/10.18632/aging.101281
How to Cite

Copyright: © 2017 Silva et al. This is an open access article distributed under the terms of the Creative Commons Attribution License (CC BY 3.0), which permits unrestricted use, distribution, and reproduction in any medium, provided the original author and source are credited.

Abstract

Obesity and aging are associated with hypothalamic inflammation, hyperphagia and abnormalities in the thermogenesis control. It has been demonstrated that the association between aging and obesity induces hypothalamic inflammation and metabolic disorders, at least in part, through the atypical hypothalamic transforming growth factor-β (TGF-β1). Physical exercise has been used to modulate several metabolic parameters. Thus, the aim of this study was to evaluate the impact of chronic exercise on TGF-β1 expression in the hypothalamus of Middle-Aged mice submitted to a one year of high-fat diet (HFD) treatment. We observed that long-term of HFD-feeding induced hypothalamic TGF-β1 accumulation, potentiated the hypothalamic inflammation, body weight gain and defective thermogenesis of Middle-Aged mice when compared to Middle-Aged animals fed on chow diet. As expected, chronic exercise induced negative energy balance, reduced food consumption and increasing the energy expenditure, which promotes body weight loss. Interestingly, exercise training reduced the TGF-β1 expression and IkB-α ser32 phosphorylation in the hypothalamus of Middle-Aged obese mice. Taken together our study demonstrated that chronic exercise suppressed the TGF-β1/IkB-α axis in the hypothalamus and improved the energy homeostasis in an animal model of obesity-associated to aging.

Introduction

The aging is a natural process described such a loss of cellular functions, tissues and organs. Studies have shown that aging is a multifactorial phenomenon, but the lifestyle such as, sedentarism and poor diet habits, plays a critical role for lifespan [1]. Currently, the aging population has been increased together with sedentary lifestyle and high-caloric diet consumption, which contributed to the increase of obesity in aged people [2,3]. The obesity in the older adult is largely related with cancer risk [2] and other age-related diseases [3,4].

The hypothalamus controls energy balance and multiple metabolic signals including food intake and energy expenditure by neurotransmitters such as pro-opiomelanocortin (POMC) and neuropeptide Y (NPY) [5,6]. However, aging and obesity are associated with hypothalamic inflammation and loss of anorexigenic and thermogenic signals in the hypothalamus [6,7]. Hypothalamic inflammation is associated with several age-related diseases such as Alzheimer’s disease, obesity, diabetes type 2, cancer, sarcopenia, with significant risks of morbidity and/or mortality [8]. In this scenario, the transforming growth factor-β (TGF-β), a member of the family of pleiotropic cytokines, has been associated with hypothalamic inflammation and metabolic disorders in obese and aging mice [9].

The TGF-β protein has three different isoforms (1-3), located in the extracellular matrix and can regulate several biological cell functions such as proliferation, differentiation, migration, and survival, playing pivotal role in the morphogenesis and homeostasis [10]. This protein is expressed in different tissues including brain [9], tumor [11], corneal epithelium [12] and muscle [13]. There are some evidences that links the TGF-β1 levels with obesity and aging in rodents and humans [9,14,15]. In addition, the TGF-β1 levels were correlated with adiposity in rodents and humans [14,16]. Interestingly, the systemic treatment with anti-TGF-β1 antibody protected leptin-deficient (ob/ob) and diet-induced obese (DIO) mice against obesity and diabetes [14].

Recently, TGF-β1 was found to be highly expressed in the hypothalamus of obese and old mice [9]. Yan and colleagues showed that hypothalamic injection of TGF-β1 caused hyperglycemia and glucose intolerance in mice, conversely, the TGFβ-1 deficient mice (Tgfb1+/−) were protected from hypothalamic inflammation and type 2 diabetes induced by high-fat diet (HFD) [9]. The authors also demonstrated that TGF-β1 induced a hypothalamic RNA stress response, accelerating mRNA down regulation of IkBα that has the function of modulating negatively proinflammatory nuclear factor-κB [9]. Furthermore, the combination of poor diet consumption associated with a sedentary lifestyle during aging process may potentiate hypothalamic inflammation, stimulating central TGF-β1 expression, contributing to the metabolic syndrome, age-related disorders reducing the lifespan [6,15]. Together, these evidences indicate that hypothalamic TGF-β1 could be considered an interesting target to control energy homeostasis, nevertheless, the mechanisms by which TGF-β1 protein levels are controlled in the hypothalamus remain unclear.

In the other hand, regular exercise can protect against several diseases and contribute to health maintenance [17]. Studies have shown that some peripheral [13,1820] and central [21] benefits of exercise are associated with the reduction of TGF-β1signaling, however, the effects of physical exercise on the hypothalamic TGF-β1 protein content are unknown. Thus, the aim of this study was to determine the influence of chronic exercise on hypothalamic TGF-β1 in middle-aged obese mice.

Results

Effects of long-term of high-fat diet consumption in Middle-Aged mice

Initially, we evaluated the effects of combination between aging and long-term of high-fat diet (HFD) treatment (twelve months) on energy homeostasis in mice. Body weight, energy expenditure, brown adipose tissue and hypothalamic samples were analyzed, as shown in the experimental design Fig. 1A.

Effects of long-term of high-fat diet consumption in Middle-Age mice. Experimental design 1 (A). Body weight and epididymal fat (B and C) (n=5-8 per group). VO2 (D), CO2 (E), RER (F) (n= 4-5 per group). Ucp1 mRNA in the brown adipose tissue (n=5-8 per group) (G). The animals were fasted for 8 hours before the brown adipose tissue extraction. Data are expressed as means ± SEM. *, p&, p

Figure 1. Effects of long-term of high-fat diet consumption in Middle-Age mice. Experimental design 1 (A). Body weight and epididymal fat (B and C) (n=5-8 per group). VO2 (D), CO2 (E), RER (F) (n= 4-5 per group). Ucp1 mRNA in the brown adipose tissue (n=5-8 per group) (G). The animals were fasted for 8 hours before the brown adipose tissue extraction. Data are expressed as means ± SEM. *, p<0.05 vs Young control group and &, p<0.05 vs Middle-Age fed on chow diet.

The Middle-Aged mice (16-months old) fed on chow diet presented only a discrete body weight gain, but significant epididymal fat pad gain when compared to young control group (4-months old) (Fig. 1B and C). Also, these mice displayed lower values of VO2 consumption, CO2 production and respiratory exchange ratio (RER) in the dark period when compared to young control group (Fig. 1D-F). Consistent with these findings, Middle-Aged mice presented low levels of Ucp1 mRNA in BAT (Fig.1G).

Thereafter, we evaluated the effects of HFD treatment in Middle-Aged mice. The long-term of HFD treatment increased body weight and epididymal fat pad mass gain when compared to other groups (Fig. 1B and C). The HFD consumption affected the CO2 production and respiratory exchange ratio (RER) in the dark period when compared to young and Middle-Aged mice fed on chow diet (Fig. 1E and F). The Ucp1 mRNA levels in the brown adipose tissue were reduced in the Middle-Aged mice after HFD treatment when compared to young control group, but no difference was observed when compared to Middle-Aged mice fed on chow diet (Fig. 1G). Overall, these results suggest that long term of HFD treatment potentiates the abnormalities in the control of body weight gain and the thermogenesis of Middle-Aged mice.

Long-term of HFD treatment increased hypothalamic TGF-β1 accumulation and inflammatory genes in Middle-Aged mice

Next, we observed slight augment of the Tgf-β-1 mRNA levels in the hypothalamus of Middle-Aged mice when compared to young control group, but no statistical difference was found (Fig. 2A). However, the long-term of HFD treatment markedly increased the Tgf-β-1 mRNA levels in the hypothalamus when compared to other groups (Fig. 2A). This phenomenon was accompanied by high levels of inflammatory markers Tumor Necrosis Factor Alpha (Tnf-α), Interleukin-1-Beta (Il1-β), Toll-Like- Receptor 4 (Tlr4), and F4/80 mRNA levels in the hypothalamic samples of Middle-Aged mice fed on HFD when compared to young control and Middle-Aged mice fed on chow diet (Fig. 2B). Both, aging and HFD increased the Npy mRNA levels in the hypothalamus when compared to young control group (Fig. 2C).

Effects of long-term of HFD on hypothalamic TGF-β1 accumulation and inflammatory genes in Middle-Age mice. Real time PCR assay of hypothalamic Tgf-β1 (A), Tnf-α, Il1-β, Tlr4, F4/80 (B) and Npy mRNA level (C) (n=4-7 per group). The animals were fasted for 8 hours before the hypothalamus extractions. Data are expressed as means ± SEM. *, p&, p

Figure 2. Effects of long-term of HFD on hypothalamic TGF-β1 accumulation and inflammatory genes in Middle-Age mice. Real time PCR assay of hypothalamic Tgf-β1 (A), Tnf-α, Il1-β, Tlr4, F4/80 (B) and Npy mRNA level (C) (n=4-7 per group). The animals were fasted for 8 hours before the hypothalamus extractions. Data are expressed as means ± SEM. *, p<0.05 vs Young control group and &, p<0.05 vs Middle-Age fed on chow diet.

We also monitored the Tgf-β1 mRNA levels in the BAT. Interestingly, Tgf-β1 mRNA levels were reduced in Middle-Aged groups when compared to young control group (Fig. S1A). Thus, these results suggest that HFD consumption potentiates the hypothalamic TGF-β1 expression and the inflammatory profile in Middle-Aged mice.

Chronic exercise reduces body weight and restores thermogenesis in Middle-Aged obese mice

After these preliminary results, we hypothesized that the physical exercise could be an interesting physiological stimulus for modulating the hypothalamic TGF-β1 levels in our experimental model. Thus, we performed an experiment to analyze the effects of chronic exercise only in the Middle-Aged obese mice, as presented in the experimental design in Fig. 3A.

Effects of chronic exercise in Middle-Aged obese mice. Experimental design 2 (A). Body weight change, cumulative food intake and average food intake (A-D) (n=10 per group). VO2 (E), CO2 (F) and ambulatory activity (G) (n= 4 per group). All analyses were made in the last day of training. Western blotting of UCP-1 protein level in BAT (H) and normalization of protein level by Tubulin (right) (I), picture of BAT, highlighting the coloration (J) (n= 6 per group). Data are expressed as means ± SEM. *, p

Figure 3. Effects of chronic exercise in Middle-Aged obese mice. Experimental design 2 (A). Body weight change, cumulative food intake and average food intake (A-D) (n=10 per group). VO2 (E), CO2 (F) and ambulatory activity (G) (n= 4 per group). All analyses were made in the last day of training. Western blotting of UCP-1 protein level in BAT (H) and normalization of protein level by Tubulin (right) (I), picture of BAT, highlighting the coloration (J) (n= 6 per group). Data are expressed as means ± SEM. *, p<0.05 vs Sedentary group.

We first evaluated some physiological parameters in response to the exercise training. Chronic exercise reduced the body weight and cumulative food in Middle-Aged obese mice when compared to the Middle-Aged obese sedentary group (Fig. 3B and C). We observed that cumulative food consumption day by day started to reduce significantly from the eleventh day of training (Fig. 3C). The average of food intake during the experiment was also lower in the exercised group (Fig. 3D). The VO2 consumption was increased in the light cycle in exercised group (Fig. 3E). A slight augment on VO2 consumption and CO2 production in the dark period was observed in the exercised Middle-Aged obese mice when compared to the Middle-Aged obese sedentary group, but no statistical differences were detected (Fig. 3E and F). No difference was found in the ambulatory activity between the groups (Fig. 3G). The analysis of ambulatory activity showed differences in just one point at the light cycle (Fig. S2A). Although the exercise increased modestly the VO2 consumption and CO2 production, the Western blot analysis demonstrated a significant augment of UCP1 protein content in BAT (Fig. 3H and I). Consistent with these data, we observed a visual changing in the coloration of brown adipose tissue (Fig. 3J). These results demonstrated that the chronic exercise-induced a negative energy balance, reducing the food consumption and increasing the energy expenditure in Middle-Aged obese mice.

Chronic exercise reduces TGF-β1 levels and suppresses the inflammatory signaling in the hypothalamus of Middle-Aged obese mice

Next, we examined whether chronic exercise could regulate the hypothalamic TGF-β1 pathway. This phenomenon could be important once TGF-β1 induces hypothalamic RNA stress response that activates NFkB signaling and accelerates down-regulation of IkBα and proinflammatory pathways [9]. Thus, beyond the TGF-β1 we also investigated the hypothalamic IκB-α phosphorylation in Middle-Aged obese mice.

The chronic exercise reduced the hypothalamic IκB-α phosphorylation when compared to the Middle-Aged obese sedentary group (Fig. 4A and B). This data was accompanied by a strong reduction of TGF-β1 protein levels in exercised mice (Fig. 4C and D). Finally, we also analyzed the serum and hypothalamic levels of IL-6, but no difference was found in these parameters (p=0.3066 for serum level and p=0.1960 for hypothalamus) (Fig. S2B and C). Collectively, our results suggest that the chronic exercise can help to control hypothalamic TGF-β1/IκB-α axis in Middle-Aged obese mice.

Effects of chronic exercise on hypothalamic TGF-β1 protein levels in Middle-Aged obese mice. Western blotting of IkB-α ser32 phosphorylation (A) and TGF-β1 protein level (C) and Protein level normalization with Tubulin (right) (B and D) (n= 8 per group). All analyses were made after the last day of training. Data are expressed as means ± SEM. *, p

Figure 4. Effects of chronic exercise on hypothalamic TGF-β1 protein levels in Middle-Aged obese mice. Western blotting of IkB-α ser32 phosphorylation (A) and TGF-β1 protein level (C) and Protein level normalization with Tubulin (right) (B and D) (n= 8 per group). All analyses were made after the last day of training. Data are expressed as means ± SEM. *, p<0.05 vs Sedentary group.

Discussion

The obesity in elderly people is correlated with cancer and other age-related diseases [24]. Aging can affect several physiological functions during the life. Some of these metabolic and physiological dysfunctions are intimately associated with inflammatory responses that can reduce lifespan. The hypothalamic inflammation is associated with several metabolic abnormalities, which reduces lifespan [6,22]. Conversely, regular exercise can improve several metabolic parameters, reversing or attenuating chronic diseases [23]. Here, we report that mice that consumed HFD during the aging process had high TGF-β1 protein levels and increased hypothalamic inflammatory responses, which regulated negatively their energy homeostasis. However, chronic exercise reduced the TGF-β1 protein levels and attenuated the inflammatory signaling in the hypothalamus, modulating the body weight and energy expenditure in Middle-Aged obese mice.

Studies have shown that TGF-β1, a family of pleiotropic cytokines, is associated with the development of obesity, diabetes type 2, cancer anorexia and aging [9,11,14,15]. Lin et al. showed that the serum levels of TGF-β1 have a positive correlation with age, lifestyle, cigarette smoking and alcohol drinking in humans [15]. In addition, it has been reported that TGF-β1 serum levels are increased in ob/ob mice, HFD fed mice and obese humans [14,15]. In the present study, we observed that sedentary mice that consumed HFD during the long part of their life acquired an obese phenotype and displayed strong increases of hypothalamic TGF-β1 protein levels. These results are in accordance with other study showing that obesity and aging increased hypothalamic TGF-β1 levels [9]. In our study, we observed that, at least, in 16-months-old mice fed on chow diet, the age did not affect significantly the hypothalamic TGF-β1 mRNA levels. Probably, the hypothalamic TGF-1β accumulation begins to increase in Middle Age and reaches higher concentrations in older animals, however, the chronic HFD feeding accelerates this process in Middle-Age animals.

The long-term of HFD treatment strongly modulated classical inflammatory markers such as Tnf-α, Il1-β, Tlr4 and F4/80 mRNA levels in the hypothalamus of Middle-Aged animals. These inflammatory markers can negatively regulate the energy homeostasis, linking some age- and obesity-related metabolic disorders [2428]. The central NPY signaling controls food intake and energy expenditure in mammals and plays an important role in the control of energy homeostasis [6]. Here, we found that independent of the type of the diet, the Npy mRNA levels were increased in Middle-Aged sedentary mice. However, the HFD feeding did not promoted an additional effect on NPY mRNA levels in Middle-Age mice. Besides that, it has been shown that the Npy mRNA levels increase after 2 weeks and decrease after 12 weeks of HFD treatment [29,30], demonstrating that chronic exposure to HFD induces NPY mRNA stabilization in the hypothalamus and other mechanisms cold be involved in the body weight gain during the long-term of HFD treatment.

The TGF-β may have pro- or anti-inflammatory effects in different tissues, however, the mechanism for this regulation remains unclear [31,32]. Rao et al showed that meteorin-like 1 (Metrnl), a circulating factor produced by muscle contraction after exercise and in adipose tissue in low temperatures, increased Ucp1 mRNA expression, which was accompanied by an increase of the anti-inflammatory genes Il-10 and Tgf-β mRNA levels in BAT [31]. Yadav and colleagues showed that an intraperitoneal injection of TGF-β1 reduced the UCP1 protein levels in lean mice [14]. Here, we found that Tgf-β1 mRNA levels were decreased in BAT of Middle-Aged fed on HFD, which was accompanied by a reduction of Ucp1 mRNA levels as described by Rao et al [31]. Although, we consider the possibility that TGF-β1 can exert an anti-inflammatory role in BAT, further studies are necessary to explain this duality.

It has been demonstrated that TGF-β1 levels are correlated the with body mass index (BMI), fat mass, and VO2 consumption in humans. In addition, high TGF-β1 levels were associated with atypical metabolic profile [14]. In this study, we detected a reduced VO2 consumption, CO2 production, and RER in Middle-Aged mice with higher hypothalamic TGF-β1 levels. The strong reduction in the RER of the Middle-Aged fed on HFD indicates that this group could use more fat as an energy source [33] or develops an energy expenditure dysfunction. To evaluate the energy expenditure, we also monitored the UCP1 in the brown adipose tissue. It is important to point out that BAT dysfunction may play important roles in some metabolic disorders such as obesity, diabetes, and cardiovascular disease [34], as well as during the aging process [35,36]. We found that Ucp1 mRNA levels were decreased in the BAT of Middle-Aged groups, without additional effects after the long-term of HFD treatment.

Regular exercise has the ability to improve thermogenic capacity by the activation of proteins in the brown adipose tissue such as UCP1, protecting against body fat accumulation and other metabolic diseases [37]. We verified an increase in the energy expenditure and an overexpression of UCP1 (~200%) in Middle-Aged obese mice after the chronic exercise. Also, we observed an intensification of reddish coloration of BAT in the exercised animals when compared to the sedentary group. These data suggest that both the number of mitochondria and thermogenic capacity of BAT were increased [38]. These findings are interesting and show that regular exercise modulated the energy expenditure in Middle-Aged obese mice.

It has been demonstrated that exercise modulates several inflammatory and anti-inflammatory markers in the body. For instance, the physical exercise stimulates the IL-6, a cytokine, describe as inflammatory and anti-inflammatory molecule [39,40]. We previously reported that acutely exercise suppressed the energy intake in obese rodents via IL-6 central action [39]. In the present study, we monitored the peripheral and central levels of IL-6 and we confirmed that IL-6 was not involved in the reduction of food consumption during the chronic exercise.

Strategies to control peripheral and central TGF-β1 signalling may be an innovative strategy for preventing metabolic and inflammatory diseases as well as age-related disorders. Therefore, we used chronic exercise, a non-pharmacologic and non-invasive strategy, for the control of diseases, as previously described [17]. Kim and Lee demonstrated that twenty-four days of swimming exercise was able to decrease TGF-β1 levels in vascular fibrosis in aged obese rats [41]. Böhm and collaborators showed that eight weeks of training reduced the TGF-β levels in skeletal muscle in twenty Middle-Aged subjects, while muscular TGF-β expression was associated with the decline of mitochondrial oxidation and insulin sensitivity [13]. Similar results were found by Pincu et al. [18] and Touvra et al. [19]. Thus, for the first time, we showed that moderate chronic exercise reduced the TGF-β1 protein levels (~75%) and IκB-α phosphorylation (~50%) in the hypothalamus of Middle-Aged obese mice. Interestingly, these data were accompanied by a reduction of food consumption and body weight.

In conclusion, we identified that HFD-feeding during the aging process induced TGF-β1 accumulation and inflammatory genes in the hypothalamus of Middle-Aged obese mice. These data were accompanied by body weight gain and modification in the energy expenditure pattern. However, chronic exercise reduced the TGF-β1 protein levels and the inflammatory signalling. In parallel, exercise protected against obesity, reducing the food consumption and increasing thermogenesis. Taken together, these data suggest that regular physical exercise can control energy homeostasis at least in part, through the reduction of the hypothalamic TGF-β1/IκB-α axis in Middle-Aged obese mice.

Materials and Methods

Animals and diet

Four-months-old male C57BL/6J mice were obtained from the University of Campinas Breeding Center (CEMIB). The animals were randomly separated into two groups: One group consumed standard chow diet (Chow) (3.948 kcal·kg-1), while the other group consumed high-fat diet (HFD) (5.358 kcal·kg-1) ad libitum for twelve months. Four-months-old C57BL/6J mice were used as a control group. (see Table 1 and experimental design 1 Figure 1A). Next, part of these mice that consumed HFD for twelve months were submitted to the chronic swimming exercise protocol (Exercise group), and the respective control group was maintained sedentary (Sedentary group). During this experimental period, these animals were maintained in a 12:12 hour light and dark cycle and housed in cages between 22–24ºC with free access to food and water. The light cycle started at 6:00 am. The experiments were approved by the ethics committee of the University of Campinas (number:2736-1), which follows the international guidelines for the use of animals in experimental studies and experiments.

Table 1. Components of standard chow diet and high-fat diet.

IngredientsStandard chowStandard chow
g kg−1kcal kg−1g kg−1kcal kg−1
Cornstarch (Q.S.P.)397.51590115.5462
Casein200800200800
Sucrose100400100400
Dextrinated starch132528132528
Lard--3122808
Soybean Oil7063040360
Cellulose50-50-
Mineral Mix35-35-
Vitamin Mix10-10-
L-Cystine3-3-
Choline2.5-2.5-
Total1000394810005358
Consume standard chow diet (Chow) (3.948 kcal•kg-1) and high-fat diet (HFD) (5.358 kcal•kg-1) ad libitum for twelve months.

Chronic exercise protocol

Mice were acclimated to swimming for two days, ten minutes per day. Water temperature was maintained at 32 °C. The mice swam in groups of four in plastic barrels of 40 cm in diameter that were filled to a depth of 20 cm for one hour, during five days per twenty days. Extractions of tissue were performed after the last session of the exercise protocol.

Food consumption

Cumulative food consumption and body weight measurements were monitored every day during the exercise protocol in individual cages.

Brown adipose tissue (BAT) photos

Images were taken immediately after extraction of BAT.

Oxygen consumption determination

Mice were acclimated for 24 hours to an open-circuit indirect calorimeter system. The Comprehensive Lab Animal Monitoring System: Oxymax-CLAMS (Columbus Instruments, OH-USA) was calibrated as recommended by the manufacturer and used to measure the rate of O2 consumption (VO2), CO2 production (VCO2), respiratory exchange ratio (RER), heat rate (Kcal/h) and ambulatory activity during the light and dark periods. These data were acquired for 24 hours and were analyzed using Oxymax Windows software.

Determination of IL6 levels

Mice were anesthetized, and blood was collected from the cava vein immediately after the last session of chronic exercise. Plasma was separated by centrifugation (1.100 x g) for 15 minutes at 4 °C and stored at -80 °C until the assay. IL-6 concentrations were determined using a commercially available ELISA kit IL-6 Mouse for mice (Invitrogen Life Tech KMC0062) following the manufacturer’s instructions.

Antibodies and chemicals

Nitrocellulose paper (Hybond ECL, 0.45 mm) was supplied by Amersham Pharmacia Biotech United Kingdom Ltd. (Buckinghamshire, United Kingdom). Ketamine was from Parke-Davis (São Paulo, SP, Brazil), diazepam and thiopental were from Cristália (Itapira, SP, Brazil). Anti-TGF-β (rabbit polyclonal, ab66043) was from Abcam plc. anti-phospho IκB-α (ser32) rabbit polyclonal SC7977-R), anti-UCP1 (goat polyclonal, M-17: SC-6529) antibodies were from Santa Cruz Biotechnology, Inc. anti-Tubulin (rabbit polyclonal, #2146), anti-β-actin (rabbit polyclonal, #4967) were from Cell Signaling Technology (Beverly, MA, USA). The antibody solution was 1:1000 for Western blots. Routine reagents were purchased from Sigma Chemical Co. (St. Louis, MO, USA).

Protein analysis by immunoblotting

The hypothalamus and brown adipose tissue (BAT) were quickly removed and immediately frozen in liquid nitrogen. Then, the samples were minced coarsely and homogenized immediately as previously described [28]. The membranes were exposed to specific primary and secondary antibodies. After that, the membranes were exposed to SuperSignalTM West Pico Chemiluminescent Substrate (Thermo Scientific), and the bands were analyzed by UN-SCAN-IT gel, 6.1. The whole membranes and the statistical analyses are presented in the Supplementary Figure 3.

mRNA Isolation and Real-Time PCR

Total RNA content of brown adipose tissue (BAT) and hypothalamus was extracted using Rneasy® Mini Kit and QIAcube equipment by QIAGEN. The protocol was followed according to the recommendations of the manufacturer. In the exercised group, BAT was extracted after the last (20th) session of exercise. 2.0 mg of total RNA was reverse transcribed with High Capacity cDNA Kit (Applied Biosystems, Foster City, California, EUA). Real-time PCR was performed using 20ng of cDNA, 0.25ml of each primer, 3.0ml of TaqMan® Fast Advanced Master Mix (Applied Biosystems, Foster City, California, EUA) and RNase-free water to a total volume of 10ml. Data were analyzed based on the 2^-dct method. Primers used for hypothalamus and Bat analyses were: Tgfβ:Mm03024053_m1; Tnf:Mm00443258_m1; Il1-β: m00434228_ml;Il10:Mm01288386_m1;Tlr4:Mm00445273_m1;F4/80:;Mm00802529_m1;Npy:Mm01410146_m1;Ucp1:Mm01244861_m1. Mouse GAPD (GAPDH) Endogenous Control (Catalog number: 4352339E).

Statistical analysis

All statistical analyses were performed using the Student’s t-test (comparisons between two groups) or one-way ANOVA (comparisons between more than two groups) with the Newman-Keuls Multiple Comparison test. For the Western blotting analysis, we used comparisons and quantified by optical densitometry (UN-SCAN-IT gel, 6.1). Significance was established at the mean ± SEM. p<0.05 level.

Supplementary Materials

Supplementary File

Author Contributions

V.R.R.S, C.K.K and E.R.R discussed and designed this study. V.R.R.S and E.R.R organized and wrote the manuscript. V.R.R.S; C.K.K; L.L and C.G.B.S performed the experiments. R.L.C performed the CLAMS experiments. J.M performed Real time PCR. L.A.V; M.A.S; A.S.R.S and J.R.P contributed for technical support and discussion of manuscript.

Acknowledgements

We would like to thank Sandra Brambilla for technical assistance and The Obesity and Comorbidities Research Center (OCRC) for technical and financial support.

Conflicts of Interest

The authors declare no conflicts of interest in this study.

Funding

This work was supported by Fundação de Amparo à Pesquisa do Estado de São Paulo (FAPESP) (Process number – 2016/01089-3).

References

  • 1. Dato S, Rose G, Crocco P, Monti D, Garagnani P, Franceschi C, Passarino G. The genetics of human longevity: an intricacy of genes, environment, culture and microbiome. Mech Ageing Dev. 2017Epub ahead of print. https://doi.org/10.1016/j.mad.2017.03.011 [PubMed]
  • 2. Freisling H, Arnold M, Soerjomataram I, O’Doherty MG, Ordóñez-Mena JM, Bamia C, Kampman E, Leitzmann M, Romieu I, Kee F, Tsilidis K, Tjønneland A, Trichopoulou A, et al. Comparison of general obesity and measures of body fat distribution in older adults in relation to cancer risk: meta-analysis of individual participant data of seven prospective cohorts in Europe. Br J Cancer. 2017; 116:1486–97. https://doi.org/10.1038/bjc.2017.106 [PubMed]
  • 3. Nadrowski P, Chudek J, Skrzypek M, Puzianowska-Kuźnicka M, Mossakowska M, Więcek A, Zdrojewski T, Grodzicki T, Kozakiewicz K. Associations between cardiovascular disease risk factors and IL-6 and hsCRP levels in the elderly. Exp Gerontol. 2016; 85:112–17. https://doi.org/10.1016/j.exger.2016.10.001 [PubMed]
  • 4. Joo E, Fukushima T, Harada N, Reed JC, Matsuzawa SI, Inagaki N. Ubc13 haploinsufficiency protects against age-related insulin resistance and high-fat diet-induced obesity. Sci Rep. 2016; 6:35983. https://doi.org/10.1038/srep35983 [PubMed]
  • 5. Sousa-Ferreira L, de Almeida LP, Cavadas C. Role of hypothalamic neurogenesis in feeding regulation. Trends Endocrinol Metab. 2014; 25:80–88. https://doi.org/10.1016/j.tem.2013.10.005 [PubMed]
  • 6. Cavadas C, Aveleira CA, Souza GF, Velloso LA. The pathophysiology of defective proteostasis in the hypothalamus - from obesity to ageing. Nat Rev Endocrinol. 2016; 12:723–33. https://doi.org/10.1038/nrendo.2016.107 [PubMed]
  • 7. Cai D, Liu T. Hypothalamic inflammation: a double-edged sword to nutritional diseases. Ann N Y Acad Sci. 2011; 1243:E1–39. https://doi.org/10.1111/j.1749-6632.2011.06388.x [PubMed]
  • 8. Fougère B, Boulanger E, Nourhashémi F, Guyonnet S, Cesari M. Chronic Inflammation: Accelerator of Biological Aging. J Gerontol A Biol Sci Med Sci. 2016glw240. https://doi.org/10.1093/gerona/glw240 [PubMed]
  • 9. Yan J, Zhang H, Yin Y, Li J, Tang Y, Purkayastha S, Li L, Cai D. Obesity- and aging-induced excess of central transforming growth factor-β potentiates diabetic development via an RNA stress response. Nat Med. 2014; 20:1001–08. https://doi.org/10.1038/nm.3616 [PubMed]
  • 10. Shi M, Zhu J, Wang R, Chen X, Mi L, Walz T, Springer TA. Latent TGF-β structure and activation. Nature. 2011; 474:343–49. https://doi.org/10.1038/nature10152 [PubMed]
  • 11. Tsai VW, Lin S, Brown DA, Salis A, Breit SN. Anorexia-cachexia and obesity treatment may be two sides of the same coin: role of the TGF-b superfamily cytokine MIC-1/GDF15. Int J Obes. 2016; 40:193–97. https://doi.org/10.1038/ijo.2015.242 [PubMed]
  • 12. Li ZY, Chen ZL, Zhang T, Wei C, Shi WY. TGF-β and NF-κB signaling pathway crosstalk potentiates corneal epithelial senescence through an RNA stress response. Aging (Albany NY). 2016; 8:2337–54. https://doi.org/10.18632/aging.101050 [PubMed]
  • 13. Böhm A, Hoffmann C, Irmler M, Schneeweiss P, Schnauder G, Sailer C, Schmid V, Hudemann J, Machann J, Schick F, Beckers J, Hrabě de Angelis M, Staiger H, et al. TGF-β Contributes to Impaired Exercise Response by Suppression of Mitochondrial Key Regulators in Skeletal Muscle. Diabetes. 2016; 65:2849–61. https://doi.org/10.2337/db15-1723 [PubMed]
  • 14. Yadav H, Quijano C, Kamaraju AK, Gavrilova O, Malek R, Chen W, Zerfas P, Zhigang D, Wright EC, Stuelten C, Sun P, Lonning S, Skarulis M, et al. Protection from obesity and diabetes by blockade of TGF-β/Smad3 signaling. Cell Metab. 2011; 14:67–79. https://doi.org/10.1016/j.cmet.2011.04.013 [PubMed]
  • 15. Lin Y, Nakachi K, Ito Y, Kikuchi S, Tamakoshi A, Yagyu K, Watanabe Y, Inaba Y, Kazuo Tajima, and Jacc Study Group. Variations in serum transforming growth factor-beta1 levels with gender, age and lifestyle factors of healthy Japanese adults. Dis Markers. 2009; 27:23–28. https://doi.org/10.1155/2009/529253 [PubMed]
  • 16. Fain JN, Tichansky DS, Madan AK. Transforming growth factor beta1 release by human adipose tissue is enhanced in obesity. Metabolism. 2005; 54:1546–51. https://doi.org/10.1016/j.metabol.2005.05.024 [PubMed]
  • 17. Pedersen BK, Saltin B. Exercise as medicine - evidence for prescribing exercise as therapy in 26 different chronic diseases. Scand J Med Sci Sports. 2015 (Suppl 3); 25:1–72. https://doi.org/10.1111/sms.12581 [PubMed]
  • 18. Pincu Y, Linden MA, Zou K, Baynard T, Boppart MD. The effects of high fat diet and moderate exercise on TGFβ1 and collagen deposition in mouse skeletal muscle. Cytokine. 2015; 73:23–29. https://doi.org/10.1016/j.cyto.2015.01.013 [PubMed]
  • 19. Touvra AM, Volaklis KA, Spassis AT, Zois CE, Douda HD, Kotsa K, Tokmakidis SP. Combined strength and aerobic training increases transforming growth factor-β1 in patients with type 2 diabetes. Hormones (Athens). 2011; 10:125–30. https://doi.org/10.14310/horm.2002.1302 [PubMed]
  • 20. Heinemeier K, Langberg H, Kjaer M. Exercise-induced changes in circulating levels of transforming growth factor-beta-1 in humans: methodological considerations. Eur J Appl Physiol. 2003; 90:171–77. https://doi.org/10.1007/s00421-003-0881-8 [PubMed]
  • 21. Kang EB, Koo JH, Jang YC, Yang CH, Lee Y, Cosio-Lima LM, Cho JY. Neuroprotective Effects of Endurance Exercise Against High-Fat Diet-Induced Hippocampal Neuroinflammation. J Neuroendocrinol. 2016; 28. https://doi.org/10.1111/jne.12385 [PubMed]
  • 22. Zhang G, Li J, Purkayastha S, Tang Y, Zhang H, Yin Y, Li B, Liu G, Cai D. Hypothalamic programming of systemic ageing involving IKK-β, NF-κB and GnRH. Nature. 2013; 497:211–16. https://doi.org/10.1038/nature12143 [PubMed]
  • 23. Fan W, Evans RM. Exercise Mimetics: Impact on Health and Performance. Cell Metab. 2017; 25:242–47. https://doi.org/10.1016/j.cmet.2016.10.022 [PubMed]
  • 24. Loh K, Herzog H, Shi YC. Regulation of energy homeostasis by the NPY system. Trends Endocrinol Metab. 2015; 26:125–35. https://doi.org/10.1016/j.tem.2015.01.003 [PubMed]
  • 25. Ma Y, Gao M, Liu D. Preventing High Fat Diet-induced Obesity and Improving Insulin Sensitivity through Neuregulin 4 Gene Transfer. Sci Rep. 2016; 6:26242. https://doi.org/10.1038/srep26242 [PubMed]
  • 26. Alomar SY, Gentili A, Zaibi MS, Kępczyńska MA, Trayhurn P. IL-1β (interleukin-1β) stimulates the production and release of multiple cytokines and chemokines by human preadipocytes. Arch Physiol Biochem. 2016; 122:117–22. https://doi.org/10.3109/13813455.2016.1156706 [PubMed]
  • 27. Milanski M, Degasperi G, Coope A, Morari J, Denis R, Cintra DE, Tsukumo DM, Anhe G, Amaral ME, Takahashi HK, Curi R, Oliveira HC, Carvalheira JB, et al. Saturated fatty acids produce an inflammatory response predominantly through the activation of TLR4 signaling in hypothalamus: implications for the pathogenesis of obesity. J Neurosci. 2009; 29:359–70. https://doi.org/10.1523/JNEUROSCI.2760-08.2009 [PubMed]
  • 28. Silva VR, Katashima CK, Bueno Silva CG, Lenhare L, Micheletti TO, Camargo RL, Ghezzi AC, Camargo JA, Assis AM, Tobar N, Morari J, Razolli DS, Moura LP, et al. Hypothalamic S1P/S1PR1 axis controls energy homeostasis in Middle-Aged Rodents: the reversal effects of physical exercise. Aging (Albany NY). 2016; 9:142–55. https://doi.org/10.18632/aging.101138 [PubMed]
  • 29. Camargo RL, Batista TM, Ribeiro RA, Branco RC, Da Silva PM, Izumi C, Araujo TR, Greene LJ, Boschero AC, Carneiro EM. Taurine supplementation preserves hypothalamic leptin action in normal and protein-restricted mice fed on a high-fat diet. Amino Acids. 2015; 47:2419–35. https://doi.org/10.1007/s00726-015-2035-9 [PubMed]
  • 30. Levin BE, Dunn-Meynell AA. Reduced central leptin sensitivity in rats with diet-induced obesity. Am J Physiol Regul Integr Comp Physiol. 2002; 283:R941–48. https://doi.org/10.1152/ajpregu.00245.2002 [PubMed]
  • 31. Rao RR, Long JZ, White JP, Svensson KJ, Lou J, Lokurkar I, Jedrychowski MP, Ruas JL, Wrann CD, Lo JC, Camera DM, Lachey J, Gygi S, et al. Meteorin-like is a hormone that regulates immune-adipose interactions to increase beige fat thermogenesis. Cell. 2014; 157:1279–91. https://doi.org/10.1016/j.cell.2014.03.065 [PubMed]
  • 32. Sanjabi S, Zenewicz LA, Kamanaka M, Flavell RA. Anti-inflammatory and pro-inflammatory roles of TGF-beta, IL-10, and IL-22 in immunity and autoimmunity. Curr Opin Pharmacol. 2009; 9:447–53. https://doi.org/10.1016/j.coph.2009.04.008 [PubMed]
  • 33. Kaiyala KJ, Ramsay DS. Direct animal calorimetry, the underused gold standard for quantifying the fire of life. Comp Biochem Physiol A Mol Integr Physiol. 2011; 158:252–64. https://doi.org/10.1016/j.cbpa.2010.04.013 [PubMed]
  • 34. Chondronikola M, Volpi E, Børsheim E, Porter C, Saraf MK, Annamalai P, Yfanti C, Chao T, Wong D, Shinoda K, Labbė SM, Hurren NM, Cesani F, et al. Brown Adipose Tissue Activation Is Linked to Distinct Systemic Effects on Lipid Metabolism in Humans. Cell Metab. 2016; 23:1200–06. https://doi.org/10.1016/j.cmet.2016.04.029 [PubMed]
  • 35. Graja A, Schulz TJ. Mechanisms of aging-related impairment of brown adipocyte development and function. Gerontology. 2015; 61:211–17. https://doi.org/10.1159/000366557 [PubMed]
  • 36. Yoneshiro T, Aita S, Matsushita M, Okamatsu-Ogura Y, Kameya T, Kawai Y, Miyagawa M, Tsujisaki M, Saito M. Age-related decrease in cold-activated brown adipose tissue and accumulation of body fat in healthy humans. Obesity (Silver Spring). 2011; 19:1755–60. https://doi.org/10.1038/oby.2011.125 [PubMed]
  • 37. Stanford KI, Goodyear LJ. Exercise regulation of adipose tissue. Adipocyte. 2016; 5:153–62. https://doi.org/10.1080/21623945.2016.1191307 [PubMed]
  • 38. Rossato M. Aging and brown adipose tissue activity decline in human: does the brain extinguish the fire? Aging Clin Exp Res. 2016; 28:579–81. https://doi.org/10.1007/s40520-016-0572-z [PubMed]
  • 39. Ropelle ER, Flores MB, Cintra DE, Rocha GZ, Pauli JR, Morari J, de Souza CT, Moraes JC, Prada PO, Guadagnini D, Marin RM, Oliveira AG, Augusto TM, et al. IL-6 and IL-10 anti-inflammatory activity links exercise to hypothalamic insulin and leptin sensitivity through IKKbeta and ER stress inhibition. PLoS Biol. 2010; 8:e1000465. https://doi.org/10.1371/journal.pbio.1000465 [PubMed]
  • 40. Pedersen L, Idorn M, Olofsson GH, Lauenborg B, Nookaew I, Hansen RH, Johannesen HH, Becker JC, Pedersen KS, Dethlefsen C, Nielsen J, Gehl J, Pedersen BK, et al. Voluntary Running Suppresses Tumor Growth through Epinephrine- and IL-6-Dependent NK Cell Mobilization and Redistribution. Cell Metab. 2016; 23:554–62. https://doi.org/10.1016/j.cmet.2016.01.011 [PubMed]
  • 41. Kim SY, Lee J. Exercise Training suppresses vascular fibrosis in aging obesity induced rats. J Exerc Nutrition Biochem. 2014; 18:175–80. https://doi.org/10.5717/jenb.2014.18.2.175 [PubMed]